Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC: Doravirine and Hormonal Contraceptives in Women Living With HIV
NCT04669678Phase 4Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Nov 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of doravirine in human immunodeficiency virus infection (HIV), sponsored by University of Alabama at Birmingham. Started Nov 2021; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT04669678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04669678.